Literature DB >> 7590969

Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNA.

R J Quigg1, C F Lo, J J Alexander, A E Sneed, G Moxley.   

Abstract

The rat complement regulator 5I2 antigen/Crry is present in a widespread distribution as at least two discrete proteins of Mr 65000-70000 and 75000-85000. The molecular basis for the different proteins has not been determined. We screened a cDNA library derived from cultured rat glomerular epithelial cells with a polymerase chain reaction (PCR)-generated nucleotide probe for CR1 and Crry. Two identical clones with 1.8 kilobase inserts were obtained. Clone 6.1 consisted of 1811 nucleotides. The sequence was identical to nucleotides 42-1666 of the cDNA for rat 5I2 antigen/Crry except for 11 nucleotides at the extreme 5' and 3' ends and an exact duplication of 186 bases that would encode an additional complete short consensus repeat (SCR). By reverse transcription PCR, we show that the two forms of Crry mRNA exist in all rat cells/tissues examined. It is likely that these two Crry mRNA species differ by the absence or presence of a 186 base repeat that encodes a complete SCR. These are translated into Crry proteins, containing six and seven SCRs, respectively, which explains the different sizes of Crry proteins. The role of the SCR duplication remains to be defined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590969     DOI: 10.1007/BF00179397

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  21 in total

1.  Expression of genes encoding receptors for IgG (FcRIII) and for C3b/C4b (Crry) in rat sciatic nerve during development and Wallerian degeneration.

Authors:  C A Vedeler; G Conti; P Bannerman; D Pleasure
Journal:  J Neurosci Res       Date:  1992-04       Impact factor: 4.164

2.  Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis.

Authors:  R J Quigg; V M Holers; B P Morgan; A E Sneed
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

3.  p65: A C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor.

Authors:  W W Wong; D T Fearon
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

4.  The murine complement receptor gene family. Analysis of mCRY gene products and their homology to human CR1.

Authors:  M S Paul; M Aegerter; S E O'Brien; C B Kurtz; J H Weis
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

5.  Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.

Authors:  R J Quigg; B P Morgan; V M Holers; S Adler; A E Sneed; C F Lo
Journal:  Kidney Int       Date:  1995-08       Impact factor: 10.612

6.  Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.

Authors:  B Li; C Sallee; M Dehoff; S Foley; H Molina; V M Holers
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

7.  Molecular cloning of the rat complement regulatory protein, 5I2 antigen.

Authors:  C Sakurada; H Seno; N Dohi; H Takizawa; M Nonaka; N Okada; H Okada
Journal:  Biochem Biophys Res Commun       Date:  1994-02-15       Impact factor: 3.575

8.  Studies with antibodies to cultured rat glomerular epithelial cells. Subepithelial immune deposit formation after in vivo injection.

Authors:  R J Quigg; D R Abrahamson; A V Cybulsky; J Badalamenti; A W Minto; D J Salant
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

9.  Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.

Authors:  K R Kalli; P H Hsu; T J Bartow; J M Ahearn; A K Matsumoto; L B Klickstein; D T Fearon
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.

Authors:  Y U Kim; T Kinoshita; H Molina; D Hourcade; T Seya; L M Wagner; V M Holers
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  9 in total

1.  Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.

Authors:  R J Quigg; C He; B K Hack; J J Alexander; B P Morgan
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Tissue distribution of the rat analogue of decay-accelerating factor.

Authors:  O B Spiller; S M Hanna; B P Morgan
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

3.  Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU).

Authors:  Balasubramanian Manickam; Purushottam Jha; Natalie J Hepburn; B Paul Morgan; Claire L Harris; Puran S Bora; Nalini S Bora
Journal:  Mol Immunol       Date:  2010-09-16       Impact factor: 4.407

4.  GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins.

Authors:  K D Whitney; J O McNamara
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

5.  Bacterial expression and membrane targeting of the rat complement regulator Crry: a new model anticomplement therapeutic.

Authors:  Deborah A Fraser; Claire L Harris; Richard A G Smith; B Paul Morgan
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

6.  C5a alters blood-brain barrier integrity in experimental lupus.

Authors:  Alexander Jacob; Bradley Hack; Eddie Chiang; Joe G N Garcia; Richard J Quigg; Jessy J Alexander
Journal:  FASEB J       Date:  2010-01-11       Impact factor: 5.191

Review 7.  Complement regulation in renal disease models.

Authors:  Abhijit Naik; Shweta Sharma; Richard J Quigg
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

Review 8.  Comparative functional evolution of human and mouse CR1 and CR2.

Authors:  Amanda C Jacobson; John H Weis
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

9.  Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis.

Authors:  B Schiller; C He; D J Salant; A Lim; J J Alexander; R J Quigg
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.